Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting CDK2 for cancer therapy

Cell Reports(2025)10.1016/j.celrep.2025.116140Source: DataRank Database

Targeting CDK2 for cancer therapy is a research paper published in Cell Reports (2025). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 20.21)OA: goldTopics (26)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Agnieszka K. Witkiewicz ORCID,Ioannis Sanidas ORCID,Seth M. Rubin ORCID,Erik S. Knudsen ORCID

Live enrichment

PubMed:40802510 OpenAlex:https://openalex.org/W4413117056

NIH National Institute of General Medical Sciences

Grant: R35 GM145255

National Institutes of Health National Cancer Institute

Grant: R01 CA267467

National Institutes of Health National Cancer Institute

Grant: P01 CA254867

National Institutes of Health National Cancer Institute

Grant: R01 CA275081

National Institutes of Health National Cancer Institute

Grant: R01 CA247362

FWCI

20.21

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by-nc

journalhttps://doi.org/10.1016/j.celrep.2025.116140

publisherhttps://doi.org/10.1016/j.celrep.2025.116140

publisherhttps://api.elsevier.com/content/article/PII:S2211124725009118?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124725009118?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40802510

Fields of Study

Advanced Breast Cancer TherapiesCancer-related Molecular PathwaysChronic Lymphocytic Leukemia Research

MeSH Terms

AnimalsAntineoplastic AgentsHumansNeoplasmsProtein Kinase InhibitorsCyclin-Dependent Kinase 2Molecular Targeted Therapy

Keywords

Cyclin-dependent kinaseCyclin-dependent kinase 2Cancer therapyCancer researchEpigeneticsKinaseEffectorBiologyCell cycleComputational biologyCancerCell biologyProtein kinase ABiochemistryGeneticsGene

Sustainable Development Goals

SDG 0: Good health and well-being